avatar

ASSOCIATE PROF. DR. ADLINDA BINTI ALIP

Dean Office

Faculty of Medicine

adlinda@um.edu.my
Statistics
Annual Publications by Category
Summary of Budget vs Expenditure per vote for all research grants
Latest Publication
2023

Evaluation of intrafractional prostate displacement during prostate radiotherapy using real-time ultrasound system

2023

Amivantamab plus lazertinib vs osimertinib as first-line treatment in patients with EGFR-mutated, advanced nonsmall cell lung cancer (NSCLC): Primary results from MARIPOSA, a phase III, global, randomized, controlled trial

2023

Evaluation of intrafractional prostate displacement during prostate radiotherapy using real-time ultrasound system

2023

The outcomes of glioblastoma multiforme: The University Malaya Medical Centre experience 2008-2018

2023

Amivantamab Plus Lazertinib vs Osimertinib as First-line Treatment in Patients With EGFR-mutated, Advanced Non-small Cell Lung Cancer (NSCLC): Primary Results From MARIPOSA, a Phase 3, Global, Randomized, Controlled Trial

2023

Amivantamab Plus Lazertinib vs Osimertinib as First-line Treatment Among Asian Patients With EGFR-mutated, Advanced Non-small Cell Lung Cancer (NSCLC): MARIPOSA Subgroup Analysis

2017

Abiraterone in metastatic castrate resistant prostate cancer: outcome and tolerance in real-world setting.

2016

The Treatment Outcome of Metastatic Prostate Cancer Patients Treated with Androgen Deprivation Therapy in UMMC.